2004 Fall Seminar Series

September 9, 2004

Henry Paulson, M.D., Ph.D.
Carver College of Medicine
University of Iowa
Toward Understanding Polyglutamine Neurodegeneration

September 23, 2004

Kenneth Fischbeck, M.D.
National Institute Neurological Disorders & Stroke/NIH
Hereditary Motor Neuron Disease

October 7, 2004

Cynthia McMurray, Ph.D.
Mayo Clinic
Genetics & Pathophysiology of Huntington’s Disease

October 12, 2004

Charles W. Olanow, M.D.
Mount Sinai School of Medicine
Proteasome Inhibition Model of Parkinson’s Disease

October 21, 2004

Jennifer A. Johnston
Elan Pharmaceuticals
The Ubiquitin-Proteasome Pathway in Neuronal Health & Disease

November 4, 2004

John Trojanowski, M.D., Ph.D.
University of Pennsylvania
Current Advances in Parkinson’s Research

November 11, 2004

Theodore Dawson, M.D., Ph.D.
Johns Hopkins University School of Medicine
Genetic Clues to the Mysteries of Parkinson’s Disease

November 18, 2004

Marie-Francoise Chesselet, M.D., Ph.D.
University of California-Los Angeles
Endogenous and Exogenous Stem Cells for Neural Repair in Adult Brain

December 2, 2004

Peter Lansbury, Ph.D.
Harvard Medical School
New Therapeutic Targets for Parkinson’s Disease

December 9, 2004

M. Maral Mouradian, M.D.
Department of Neurology
Robert Wood Johnson Medical School
Molecular Pathogenesis of Parkinson's Disease and Emerging Therapeutic Targets

December 16, 2004

Samuel Gandy, M.D., Ph.D., Director
Farber Institute for Neurosciences
Molecular Basis for Anti-Amyloid Therapy in Alzheimer’s Disease